BioSpace 40 Under 40 winners make their mark on biopharma

40 Under 40 honorees’ accomplishments include co-developing the world’s first synthetic biology programming language for mRNA and co-founding and leading a company acquired for $700 million up-front and up to $1.225 billion in total consideration.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top